Bortezomib, thalidomide, dexamethasone, and panobinostat for patients with relapsed multiple myeloma (MUK-six): a multicentre, open-label, phase 1/2 trial
| Image |  |
|---|---|
| Description | scientific article published on 11 November 2016 |
| Author/s |
author: Gordon Charles Cook |
| Publication date | November 11, 2016 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Access work | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |